0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biomarkers Market Research Reports

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
Cell Signaling Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Cell Signaling Market Analysis & Forecast to 2024-2034

  • Report
  • March 2024
  • 200 Pages
  • Global
From
EUR$4,150USDGBP
Biomarker Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Biomarker Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
EUR$4,150USDGBP
From
EUR$4,150USDGBP
From
EUR$3,250USDGBP
EUR$4,850USDGBP
From
EUR$3,250USDGBP
EUR$4,850USDGBP
From
EUR$3,250USDGBP
EUR$4,850USDGBP
From
EUR$695USDGBP
From
EUR$1,500USDGBP
From
EUR$1,500USDGBP
From
EUR$1,500USDGBP
From
EUR$1,500USDGBP
Loading Indicator

The Biomarkers market is a sector of the healthcare industry that focuses on the development and use of biomarkers for the diagnosis, prognosis, and treatment of diseases. Biomarkers are biological molecules that can be used to measure the presence or absence of a disease, or to monitor the progression of a disease. They can also be used to predict the response to a particular treatment. Biomarkers are typically proteins, nucleic acids, or metabolites that are found in the body and can be measured in a variety of ways. Biomarkers are used in a variety of medical applications, including cancer diagnosis and treatment, cardiovascular disease, and neurological disorders. They are also used in drug development, to identify potential drug targets and to monitor the safety and efficacy of drugs. Some of the major companies in the Biomarkers market include Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, Roche, and Sanofi. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more